Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    7569982 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand
Condition: Dystonia
Intervention: Drug: incobotulinumtoxin A

Study has passed its completion date and status has not been verified in more than two years.